Coronavirus
ETH Podcast: Creating vaccines
Research
ETH Zurich
The current episode of the ETH podcast is dedicated to the subject of production of vaccines in times of COVID-19. We've talked to two immunologists.
Artificial lung helps investigate how COVID-19 causes blood clots
Research
EPFL
Scientists at EPFL are using technology to better understand how coronavirus causes blood clots in some patients. They have developed a simplified model of a lung that lets them observe, for the first time, how the virus attacks the cells lining blood vessels.
Why we follow or don’t follow the Coronavirus rules
Research
Eawag
There are solid psychological explanations for how consistently we follow the behaviour rules to prevent the spread of Coronavirus, such as the expectations we have towards ourselves and others. These are the findings of a representative survey, the results of which can now be used to optimise public information campaigns.
Researchers develop new method to print tiny, functional organs
Research
EPFL
Researchers at EPFL have developed an approach to print tiny tissues that look and function almost like their full-sized counterpart. Measuring just a few centimeters across, the mini-tissues could allow scientists to study biological processes—and even test new treatment approaches—in ways that were previously not possible.
Patches to detect when a viral disease is about to get worse
Research
EPFL
Xsensio, an EPFL spin-off, has just been awarded CHF 1.8 million in EU funding to adapt its Lab-on-Skin™ sensing patches so that they can detect when a viral illness like the flu or COVID-19 is about to get worse.
Mechanism discovered how the coronavirus hijacks the cell
Research
ETH Zurich
Researchers at ETH Zurich and the University of Bern have discovered a mechanism by which the corona virus manipulates human cells to ensure its own replication. This knowledge will help to develop drugs and vaccines against the corona virus.
Page 10 of 25